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Background: Endotracheal re-intubation following coronary artery bypass grafting (CABG) is often associated with
significant morbidity and mortality. However, few reports have focused on the independent risk factors for
re-intubation following CABG. This study aimed to evaluate the independent risk factors for re-intubation
following CABG.
Methods: The pre-, intra-, and post-operative materials in patients who had selective and isolated CABG performed on
them from January 2004 to July 2012 in our hospital were analyzed retrospectively. Unvariate analysis and logistic
regression were used to analyze the risk factor of postoperative re-intubation following CABG.
Results: Among the 1,244 patients investigated, 97 cases suffered from postoperative re-intubation, and the incidence
rate of postoperative re-intubation was 7.8%. The in-hospital mortality in the re-intubation group was significantly
higher than that in the non-re-intubation group (9.3% versus 1.4%, P = 0.004). Re-intubation also correlated with many
negative outcomes such as pneumonia, tracheotomy, acute renal failure, infection of incision, prolonged mechanical
ventilation time, prolonged intensive care unit (ICU) stay and prolonged hospital stay. The most commonly cause of
re-intubation after CABG was hypoxemia due to cardiogenic and noncardiogenic disease, which accounted for 72.2%.
The relative factors of postoperative re-intubation were tested through unvariate analysis and logistic regression, and
the associated factors were obtained. The associated factors for re-intubation following CABG included preoperative
chronic obstructive pulmonary disease (COPD) (OR = 2.134, 95% CI = 1.472-2.967), preoperative congestive heart
failure (CHF) (OR = 2.325, 95% CI = 1.512-3.121), postoperative relative hypoxemia (OR = 2.743, 95% CI = 1.657-3.326),
postoperative acute kidney injury (AKI) (OR = 2.976, 95% CI = 2.127-4.023), postoperative total mechanical ventilation time
(OR = 1.976, 95% CI = 1.347-2.645).
Conclusion: Preoperative COPD, preoperative CHF, postoperative relative hypoxemia, postoperative AKI and
postoperative total mechanical ventilation time were five independent risk factors for re-intubation following CABG.
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With the aging of the population, rising incidence of cor-
onary artery disease (CAD) and surgical improvement of
CAD, more and more elderly patients have to be per-
formed with coronary artery bypass grafting (CABG), and
the pulmonary complications seem to be on the increase.
Some patients need to be re-intubated after the first extu-
bation. Some reports revealed that many factors and the
interaction of these factors leads to postoperative pulmon-
ary complications following CABG [1,2]. In this study, the* Correspondence: yuanzhongxiangvip@163.com
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reproduction in any medium, provided the orpre-, intro- and post- operative materials in patients
undergoing selective and isolated CABG from January
2004 to July 2012 were collected and analyzed retrospect-
ively. The associated factors were tested through descrip-
tive analysis and logistic regression, the associated factors
of postoperative re-intubation were obtained, and the aim
is to prevent and processing the conditions that led to re-
intubation and avoid the condition of ischemia and hyp-
oxia between the extubation and re-intubation after
CABG.. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Patients
The study was approved by the institutional medical ethics
committee and was consistent with the spirit of the Declar-
ation of Helsinki. Institutional Review Board of Shanghai
First People’s Hospital affiliated to Shanghai Jiaotong Uni-
versity reviews all research. From January 2004 to July
2012, 1637 patients suffering from CAD underwent CABG.
Among them 295 patients underwent CABG combined
with valve surgery and were excluded. The remaining 1342
patients underwent isolated CABG. We also excluded the
patients extubated after 48 hours or re-intubated because
of non-breathing problems such as heart arrest, re-
operation for bleeding. Thus, 1,244 consecutive patients
(912 males and 332 females, with a mean age of 67.4 ±
9.7 years) were brought into the study. Among them 97
cases were re-intubated. Coronary artery angiography re-
vealed double vessel disease in 209 patients and triple ves-
sel disease in 1035 patients, and 260 cases were concurrent
with left main trunk disease; 32 cases were concurrent with
left ventricular aneurysm. The 344 cases were performed
with off-pump CABG and 900 cases with an on-pump
CABG. The number of bypass graftings ranged from 1 to 5
( mean 2.98 per case). Left internal mammary artery was
used as a bypass conduit in 1189 (95.6%) cases and great
saphenous vein graft in 1135 (91.2%) cases. The oper-
ation was performed in Inhalation-Intravenous General
Anesthesia. Anesthesia was induced with midazolam
(2-3 mg), fentanyl (0.2 mg), propofol (0.5-1.5 mg/kg)
and vecuronium and maintained with isoflurane and
continuous infusion of propofol (2 to 5 mg/kg/h);
0.1-0.2 mg fentanyl was intravenously administered
before skin incision, sternotomy, aortic cannulation
and initiation of cardiopulmonary bypass, respectively;
total amount of fentanyl was less than 15 μg/kg during
operation). Mid-sternal incision was performed in all
cases. A blood gas analyzer (i-STAT Corporation, East
Windsor, NJ,USA) was used to measure the arterial partial
pressure of oxygeon (PaO2) and carbon dioxide (PaCO2)
peri-operatively. All post-operative patients were venti-
lated by Drager Savina respirator (Drägerwerk AG & Co.
KGaA, Lübeck, Germany).Criteria for extubation and re-intubation
Criteria for extubation included an alert and hemo-
dynamically stable patient with no excessive bleeding, abil-
ity of the patient to breathe with simultaneous intermittent
mandatory ventilation (machinery rate 4 breaths/min ,no
pressure support) for at least 30 minutes with a fraction of
inspired oxygen of less than 0.60 and a total respiratory rate
less than 25 breaths/min, an arterial blood PO2 greater than
70 mmHg, a PaCO2 less than 50 mmHg and a pH greater
than 7.35, with no metabolic acidosis. Other criteriaincluded a mandatory chest radiograph before extubation
to rule out pneumothorax, pleural effusion and atelectasis.
Criteria for re-intubation included the condition with se-
vere dyspnea and respiratory rate more than 35 breaths/
min, apparent acceleration of heartbeat and elevation of
blood pressure compared to the condition of extubation, an
arterial blood PO2 less than 60 mmHg or a PaCO2 greater
than 50 mmHg, a repeated pH lesser than 7.35 with or
without respiratory acidosis, a large-area pneumonia or
atelectasis.
Investigated data
From January 2004 to July 2012, the charts of all patients
received isolated CABG in our hospital were reviewed. The
relevant pre-, intro- and post- operative data of all selected
cases were investigated and retrospectively analyzed. The
pre-operative materials were as follows: sex, age, body mass
index (BMI), smoking history and smoking index, pre-
operative acute cardiac infarction (AMI) (evidence of AMI
within the last 30 days before surgery), preoperative renal
dysfunction (creatinine more than 2.0 mg/dl or requiring
dialysis), preoperative hypertension, preoperative diabetes,
preoperative severe chronic obstructive pulmonary diseases
(COPD) ( FEV1/FVC ratio < 70%, FEV1 < 50% predicted),
pre-operative left ventricular ejection fractions (LVEF) and
left ventricular end-diastolic diameter (LVEDD), preopera-
tive congestive heart failure (CHF, New York Heart Associ-
ation (NYHA) class III and IV), preoperative PaO2 and
PaCO2 (the value of preoperative PaO2 and PaCO2 were
obtained under no oxygen supply), hypoalbuminemia
(serum albumin less than 30 g/L), preoperative left ven-
tricular aneurysm, left main trunk disease, the number
of diseased vessels. Intraoperative data included CABG
with or without cardiopulmonary bypass, the duration
of cardiopulmonary bypass and aortic cross-clamp, by-
pass graftings, the duration of the operation. Postopera-
tive information included relative hypoxemia (the last PaO2
before extubation between 70 mmHg and 90 mmHg), rela-
tive hypercapnia (the last PaCO2 before extubation between
45 mmHg and 50 mmHg), pneumonia (Pulmonary in-
flammatory exudation in chest X-ray and positive spu-
tum culture), low cardiac output syndrome (central venous
pressure > 18 cmH2O for at least 2 hours, cardiac index <
2.5 L/m2, relative decreasing > 20% in the arterial systolic
pressure compared with basic line for at least 2 hours, dif-
ference of central and peripheral body temperature > 5°C,
conforming to the above two) , perioperative AMI (new Q-
wave infarction within 48 h after surgery), requirement of
intra-aortic balloon pump (IABP), atrial fibrillation (AF),
ventricular fibrillation (VF), acute kidney injury (AKI) (ab-
solute increase >0.3 mg/dl or relative increase >50% in the
serum creatinine level compared to the preoperative base-
line value), stroke (new permanent neurological event with
evidence of computed tomography, such as cerebral
Table 1 Comparison of morbidities and mortality
between the two groups
Re-intubation Non-re-intubation P
n = 97 n = 1147
Pneumonia 32(33%) 68(5.9%) 0.01
Tracheotomy 28(28.9%) 0(0%) <0.001
LCOS 8(8.2%) 46(4%) 0.09
AMI 1(1%) 3(0.3%) 0.08
AF 10(10.3%) 87(7.6%) 0.43
VF 1(1%) 2(0.1%) 0.08
AKI 12(12.4%) 19(1.7%) 0
Stroke 2(2.1%) 25(2.2) 0.96
Infection of incision 5(5.1%) 18(1.6%) 0.04
TMVT(days) 5.2 ± 3.5 1.6 ± 0.5 0
ICU stay(days) 5.9 ± 3.6 2.7 ± 0.7 0.01
Hospital stay(days) 14.8 ± 5.3 8.5 ± 2.6 0.01
Hospital mortality 9(9.3%) 16(1.4%) 0
LCOS: low cardiac output syndrome; AMI: acute myocardial infarction; IABP:
intro-aortic balloon pump; AF: atrial fibrillation; VF: ventricular fibrillation; AKI:














Figure 1 Time points of re-intubation following extubation.
Time points of re-intubation following extubation. Time point 0: the
same day as extubation. Time point 1: the first day after extubation.
Time point 2: the second day after extubation. Time point 3: the
third day after extubation. Time point 4: the fourth day after extuba-
tion. Time point 5: after fourth days following extubation.
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operation (re-operation to control bleeding within
36 h hours following initial surgery), infection of inci-
sion, total mechanical ventilation time, tracheotomy,
length of intensive care unit (ICU) stay, length of hospital
stay and hospital mortality (death during same admission
or within 30 days after surgery upon discharge).
Statistically analysis
Statistical analysis was performed using the SPSS17.0 statis-
tical software package. All p values <0.05 were considered
to be statistically significant. Each of the peri-operative
materials were defined as independent variables; post-
operative re-intubation (or not) following extubation was
defined as a dependent variable. Univariate analysis, using
the unpaired t-test or Satterthwaite's approximate t test
according to homogeneity test for variance to compare
measurement data and chi-square or Fisher's exact test to
compare enumeration data, was performed to assess statis-
tically significant variables, and those with p < 0.10 were
then entered into a stepwise logistic regression analysis to
identify the independent risk factors for re-intubation. The
Hosmer-Lemeshow goodness of fit coefficient was com-
puted for the regression model.
Results
1,244 consecutive patients who underwent isolated CABG
and were extubated within 48 hours were entered into this
study. Among them, 97 cases were re-intubated because
of breathing problems, accounting for 7.8%. The mean in-
tubation time in this group was 118.4 ± 87.3, while the
other group 17.4 ± 5.5 hours.
Among the re-intubation group, tracheotomy occurred
in 28 cases. Complications after re-intubation, the length
of ICU and hospital stay and in-hospital mortality are
shown in Table 1. There were significant difference in
some morbidities and mortality such as AKI, prolonged
mechanical ventilation time, length of ICU stay, length of
hospital stay and hospital mortality. Patients in the re-
intubation group had longer time of mechanical ventila-
tion, length of ICU and hospital stay and higher hospital
mortality.
Re-intubation occurred mostly on the second day after
extubation (Figure 1). The most commonly reason for re-
intubation was pulmonary edema due to CHF. The others
are as follows: hypoxemia due to pulmonary disease, car-
bon dioxide accumulation, acute respiratory tract obstruc-
tion, anaesthetic metabolic insufficiency (Figure 2). The
four cases of re-intubation due to anaesthetic metabolic
insufficiency all occurred in the same day of extubation.
Results of univariate analysis are shown in Table 2. It can
be observed that age, BMI, preoperative COPD, preopera-
tive CHF, preoperative LVEF, preoperative PaO2, postopera-
tive hypoxemia, postoperative pneumonia, postoperativeAKI and time of mechanical ventilation before re-
intubation were relative risk factors for re-intubation fol-
lowing CABG.
Those variables with p <0.10 obtained through the
univariate analysis were then entered into multivariate
logistic regression analysis (Re-intubation or not as inde-
pendent variable, variables with p <0.10 obtained through
univariate analysis as dependent variables). As shown in
Table 3, associated factors for re-intubation following
CABG included preoperative COPD (OR = 2.134, 95%
CI = 1.472-2.967), preoperative CHF (OR = 2.325, 95%
CI = 1.512-3.121), postoperative relative hypoxemia
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Figure 2 Reasons for re-intubation following CABG.
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mechanical ventilation time (OR = 1.976, 95% CI = 1.347-
2.645). The Hosmer-Lemeshow goodness of fit coefficient
of this model was 0.875.Discussion
Improvement in cardiopulmonary performance, shorter
ICU and hospital stay as well as reduction in costs could
be achieved when cardiac surgical patients were weaned
from mechanical ventilator at the appropriate time. Some-
times, appropriate prolonged ventilation support could
have contributed to avoid endotracheal re-intubation. In
this study, all the 1,244 patients were extubated within
48 hours after CABG. But among them, 97 patients were
re-intubated after first extubated, with an incidence of
7.8%. The in-hospital mortality in the re-intubation group
was more than six times that in the non-re-intubation
group (9.3% versus 1.4%, p = 0.004). Besides the in-
hospital mortality, re-intubation correlated with many
negative outcomes such as pneumonia, tracheotomy,
acute kidney injury, infection of incision, prolonged
mechanical ventilation time, prolonged ICU stay and pro-
longed hospital stay. So, it became crucial for clinicians to
evaluate the associated factors for endotracheal re-
intubation following CABG. Through univariate analysis,
the risk factors were as follows: age, BMI, preoperative
COPD, preoperative CHF, preoperative LVEF, preoperative
PaO2, postoperative relative hypoxemia, postoperative
pneumonia, postoperative AKI and time of mechanical
ventilation before re-intubation. Furthermore, through lo-
gistic regression analysis, the associated factors of re-
intubation following CABG were as follows: preoperative
COPD, preoperative CHF, postoperative relative hypox-
emia, postoperative AKI and postoperative total mechan-
ical ventilation time. The Hosmer-Lemeshow goodness of
fit of the statistical model established in this study was0.875, indicating that the model matches the data very
well, therefore the results are statistically very reliable.
Postoperative acute kidney injury was an important asso-
ciated factor for re-intubation following CABG. The mech-
anism of AKI after CABG is a complex interplay of many
factors such as low renal perfusion during cardiopulmonary
bypass, ischemic-reperfusion injury and systemic inflamma-
tory reaction syndrome (SIRS). Some studies [3,4] indicated
that SIRS and oxidative stress should be responsible for
perioperative AKI in cardiac surgery. Postoperative AKI
was an important adverse event, and was associated with
many complications such as acute renal failure, chronic dia-
lysis, prolonged ICU stay and hospital stay, higher cost and
increased mortality [5,6]. The AKI and coexisted water-
sodium retention can lead to pulmonary edema and CHF.
If the water cannot be removed timely the pulmonary com-
plication and re-intubation occurred inevitably. So patients
suffering from postoperative AKI were prone to postopera-
tive pulmonary complication even re-intubation. Thus
proper management of postoperative AKI following CABG
may contribute to reduce the incidence of re-intubation. A
stable hemodynamic condition is the key requirement for
the therapy of AKI. As a means of decreasing the risk of
AKI after cardiac surgery, statin therapy has gained more
and more attention [4]. Some drugs such as furosemide,
low-dose dopamine (2-5 μg∙kg-1 min-1), natriuretic peptide,
etc., have shown potential benefit in reducing the severity
of renal injury as well as volume overload. Strengthened di-
uretic therapy and renal replacement are two effective
methods for postoperative AKI. More and more evidence
demonstrates that continuous renal replacement therapy is
beneficial to the therapy of AKI. That beginning continuous
renal replacement therapy early is extremely important [7].
Postoperative relative hypoxemia seem to be also an as-
sociated factor for re-intubation following CABG. Among
the patients of post hypoxemia, five to fifteen percents
were re-intubated [8]. Postoperative hypoxemia may cause
Table 2 Comparison of pre-, intro- and post-operative
data between the two groups
Re-intubation Non-re-intubation P
n = 97 n = 1147
Preoperation
Female 25(25.8%) 268(23.4%) 0.65
Age (years) 64.6 ± 7.2 62.5 ± 8.1 0.05
BMI (kg/m2) 25.8 ± 2.3 24.8 ± 1.8 0.04
Smoking history 36(37.1%) 325(28.3%) 0.38
AMI 15(15.5%) 67(5.8%) 0.09
Renal dysfunction 5(5.1%) 32(2.8%) 0.25
Hypertension 43(44.3%) 526(45.9%) 0.71
Diabetes 29(29.9%) 214(18.7%) 0.12
Severe COPD 26(26.8%) 52(4.5%) 0.01
LVEF 0.52 ± 0.11 0.55 ± 0.08 0.02
LVEDD 52.9 ± 7.9 51.3 ± 5.5 0.07
CHF 21(21.6%) 48(4.2%) 0.01
PaO2 (mmHg) 72.9 ± 11.5 68.3 ± 8.6 0.04
PaCO2 (mmHg) 41.3 ± 4.1 40.9 ± 3.6 0.09
Hypoalbuminemia 2(2.1%) 21(1.8%) 0.81
Ventricular aneurysm 3(3.1%) 25(2.2%) 0.54
Left main trunk disease 8(8.2%) 79(6.9%) 0.74
Number of diseased
vessels2.8 ± 0.8
2.7 ± 0.6 0.37
Intro-operation
Use of CPB 36(37.1%) 389(33.9%) 0.79
CPB time 110.8 ± 18.6 109.5 ± 15.8 0.45
ACC time 70.4 ± 13.7 68.2 ± 12.3 0.4
Bypass graftings 3.2 ± 0.8 3.1 ± 0.7 0.88
Operation time 187.4 ± 37.9 183.9 ± 40.7 0.55
Post-operation
(before re-intubation)
Relative hypoxemia 41(42.3%) 102(8.9%) 0.02
Pneumonia 23(23.7%) 68(5.9%) 0.02
Relative hypercapnia 17(17.5%) 57(5%) 0.08
LCOS 4(4.1%) 46(4%) 0.89
AMI 1(1%) 3(0.3%) 0.08
IABP 3(3.1) 68(5.9%) 0.32
AF 15(15.5%) 87(7.6%) 0.53
VF 1(1%) 2(0.1%) 0.08
AKI 8 (8.2%) 19(1.7%) 0.01
Stroke 2(2.1%) 25(2.2) 0.96
Re-operation for bleeding 5(5.1%) 52(4.5%) 0.57
Infection of incision 2(2.1%) 18(1.6) 0.47
TMVT (days) 3.8 ± 2.5 1.6 ± 0.5 0.01
BMI: body mass index; AMI: acute myocardial infarction; COPD: chronic
obstructive pulmonary diseases; LVEF: left ventricular ejection fraction; LVEDD:
left ventricular end-diastolic dimension; CHF: chronic heart failure; CPB: cardio-
pulmonary bypass; ACC: aortic cross clamping; LCOS: low cardiac output syn-
drome; IABP; intro-aortic balloon pump; AF: atrial fibrillation; VF: ventricular
fibrillation; AKI: acute kidney injury; TMTV: total mechanical ventilation time.
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mulation and inadequate tissue perfusion can decrease
myocardial function and make homodynamic unstable.
The extent of cardiopulmonary function damage is minor
in relative hypoxemia. But if this low-level hypoxemia is
not improved it may progress to serious hypoxemia and re-
intubation following the first extubation. The reasons for
postoperative relative hypoxemia most commonly included
atelectasis and pulmonary edema. Pulmonary volume alter-
ation can also lead to the postoperative hypoxemia. Using
computed tomography, Rodrigues RR, et al. [9] investigated
postoperative pulmonary alterations and their impact on
blood oxygenation. Compared to preoperative CT, there
was a 31% postoperative reduction in pulmonary gas vol-
ume while tissue volume increased by 19%. Non-aerated
lung increased by 253 ± 97 g, from 3 to 27%, after surgery
and poorly aerated lung by 72 ± 68 g, from 24 to 27%, while
normally aerated lung was reduced by 147 ± 119 g, from 72
to 46%. So, effective measures should be taken to improve
the lung oxygenation. Prompt prolonging mechanical venti-
lation and non-invasive positive pressure ventilation (NIV)
after extubation can avoid the incidence of re-intubation ef-
fectively. NIV is safe and effective after cardiac surgery [10].
It may be beneficial to restore lung function more quickly,
safely and well accepted by patients [11]. The vital capacity
and lung volume decrease in obesity and its oxygen con-
sumption increases. The influence of small amount of
hydrothorax to obesity may he greater than that to normal
body form. So, even if the hydrothorax is not too much in
obesity it should be treated actively.
Preoperative congestive heart failure was also an import-
ant associated factor for re-intubation following CABG.
Patients suffering from preoperative CHF often had pul-
monary edema which in turn could have resulted in a
change of pulmonary ventilation/blood flow ratio, thus
resulting in postoperative hypoxemia. So, patients suffer-
ing from preoperative CHF were prone to postoperative
hypoxemia even acute respiratory distress syndrome [12].
In addition, long-term respiratory muscle overwork
may result in postoperative respiratory failure [13]. All ofTable 3 Factors for re-intubation through multivariate
logistic regression analysis
Factors OR 95% CI P
Preoperative COPD 2.13 1.472-2.967 0.02
Preoperative CHF 2.33 1.512-3.121 0.01
Postoperative relative hypoxemia 2.74 1.657-3.326 0.01
Postoperative AKI 2.98 2.127-4.023 0.01
TMVT 1.9 1.347-2.645 0.02
The Hosmer-Lemeshow goodness of fit coefficient of this model was 0.875.
OR: odds ratio; CI: confidence interval: COPD: chronic obstructive pulmonary
diseases; CHF: chronic heart failure; AKI: acute kidney injury; TMTV: total mech-
anical ventilation time.
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ventilation so far as re-intubation. Thus, proper preopera-
tive management of might contribute to reduce the inci-
dence of re-intubation and ventilation time. Besides of
positive inotropic drugs and diuretic, the natriuretic pep-
tides gained more and more attention in the treatment of
CHF during CABG. Sezai A, et al. [14] considered that in
patients with left ventricular dysfunction undergoing
CABG, human atrial natriuretic peptide (hANP) showed
renal- and cardio-protective effects and reduced postopera-
tive complications. Mentzer, et al. [15]. led the NAPA trial
in which 272 patients with underlying left ventricular dys-
function CABG using CPB were randomized to nesiritide
or placebo. Significant primary outcomes were peak in-
crease in serum creatinine, a smaller decrease in glomerular
filtration rate (GFR), a significant increase in urine output
in 24 h postoperative period, a shorter ICU stay and re-
duced early mortality with nesiritide compared to placebo.
Preoperative severe COPD was one of the key associated
factors of re-intubation following CABG. In our study,
thirteen patients with a history of severe COPD were re-
intubated due to postoperative carbon dioxide accumula-
tion. Small airway obstruction and larger physiological
dead space were observed in patients suffering from
COPD. Furthermore, the surgery of CABG with cardio-
pulmonary bypass may reduce the volumes and capacities
of lung. In addition, angina can lead to pulmonary changes
together with COPD. Gimenes C et al. [16] observed that
severe angina (class III), in association with COPD, results
in higher reductions in pulmonary pressures between the
preoperative period and the 5th postoperative day. The
above-mentioned reasons can cause obstructive and re-
strictive ventilation disorder, and decrease vital capacity
and maximal ventilation volume. So, postoperative re-
intubation could have been possible.
The most commonly cause of re-intubation after
CABG was pulmonary edema due to CHF. Secondly,
hypoxemia due to pulmonary disease was also an im-
portant cause of re-intubation. Actually, hypoxemia due
to cardiogenic and noncardiogenic disease was the main
cause of re-intubation, which accounted for more than
seventy percents. So, hypoxemia before and after extu-
bation should be managed carefully. If the PaO2 before
extubation is lower than 90 mmHg, delaying extubation
may be a better choice. Extubation should not be car-
ried out until the pulmonary edema and oxygenation
are improved. If the PaO2 after extubation is lower than
90 mmHg, non-invasive positive pressure ventilation
may be contributed to improve the oxygenation.
The retrospective nature and small sample size were
the main limitation of this study. The relatively long
time period this study covers may carry along variable
changes in operative and postoperative practices that
might have affected outcomes. The pulmonary functionmeasured preoperatively may be influenced due to the
mixing of cardiac dysfunction.
Conclusions
Preoperative COPD, preoperative CHF, postoperative rela-
tive hypoxemia, postoperative AKI and postoperative total
mechanical ventilation time were five independent risk
factors for re-intubation following CABG. Re-intubation
may be avoided by proper perioperative management of
cardiopulmonary function. Decreasing of AKI may con-
tribute to the prevention of re-intubation.
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